Nuo Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Nuo Therapeutics, Inc. (AURX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.06% for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-30
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-03-31 was 4.06%.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 1.65%, a 0.00% change year-over-year.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 1.65%, a 400.00% increase year-over-year.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 0.33%.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.08%, a 6.64% decline from fiscal 2023.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.37%, a 164.85% increase from fiscal 2022.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 1.65%, a 534.62% increase from fiscal 2021.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.26%, a 21.21% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | 4.06% 10-Q · filed 2025-07-31 | ||||
| 2025-03-31 | 4.06% 10-Q · filed 2025-04-30 | ||||
| 2024-12-31 | 4.08% 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | 4.08% 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | 4.37% 10-K · filed 2025-04-01 | ||||
| 2023-09-30 | 4.37% 10-Q · filed 2024-11-12 | ||||
| 2023-03-31 | 1.65% 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 1.65% 10-K · filed 2024-04-19 | 3.47% 10-K · filed 2023-04-17 | |||
| 2022-09-30 | 1.65% 10-Q · filed 2023-11-20 | ||||
| 2022-03-31 | 1.65% 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | 0.26% 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | 0.26% 10-Q · filed 2022-11-04 | ||||
| 2021-06-30 | 0.33% 10-Q/A · filed 2022-08-10 | ||||
| 2021-03-31 | 0.33% 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | 0.33% 10-K · filed 2022-04-15 | ||||
| 2020-09-30 | 0.33% 10-Q · filed 2022-11-04 | ||||
| 2017-03-31 | 2.10% 10-Q · filed 2017-05-15 | ||||
| 2015-06-30 | 1.60% 10-Q · filed 2015-08-13 | ||||
| 2015-03-31 | 1.60% 10-Q · filed 2015-05-14 | ||||
| 2014-06-30 | 1.60% 10-Q · filed 2015-08-13 | ||||
| 2014-03-31 | 1.60% 10-Q · filed 2015-05-14 | ||||
| 2013-12-31 | 0.77% 10-K · filed 2014-03-31 | ||||
| 2012-12-31 | 0.63% 10-K · filed 2014-03-31 | ||||
| 2011-12-31 | 1.03% 10-K · filed 2013-03-18 |